Editorial: Ozone as a Driver of Lung Inflammation and Innate Immunity and as a Model for Lung Disease. (2021)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2021.714161
PubMed Identifier: 34276707
Publication URI: http://europepmc.org/abstract/MED/34276707
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in immunology
ISSN: 1664-3224